Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 3Withdrawn 1Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Neoplasms 2Multiple Myeloma 2Hodgkin Disease 2Stomatitis 1Recurrence 1Neoplasms, Plasma Cell 1Myelodysplastic Syndromes 1Mucositis 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Hematologic Neoplasms 1Head and Neck Neoplasms 1

Interventions

Cisplatin 12Cetuximab 9pembrolizumab 7Radiotherapy 7Fluorouracil 6Carboplatin 5Radiotherapy, Intensity-Modulated 4Nivolumab 4epacadostat 3Radiation 3Docetaxel 3Venlafaxine Hydrochloride 2Surveys and Questionnaires 2Panitumumab 2Paclitaxel 2Ketamine 2zimberelimab 1vandetanib 1tislelizumab 1temsirolimus 1ruxolitinib 1plerixafor 1nimotuzumab 1linrodostat 1fosbretabulin 1fluoromisonidazole 1fludarabine phosphate 1fludarabine 1elgemtumab 1ebselen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Head and Neck Neoplasms × Fibroblast Growth Factor 7 × Clear all
NCT00540332 2009-03-02

A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy

Swedish Orphan Biovitrum

Phase 1/2 Withdrawn
Head & Neck

Head and Neck Neoplasms, Neoplasms, Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡